Allogene Therapeutics, Inc. · NASDAQ:ALLO
Capital World Investors reported a 5.60% stake in Allogene Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 13, 2025
Capital World Investors reported a 5.60% stake in Allogene Therapeutics, Inc., 12,265,330 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 12,265,330
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital World Investors | 5.60% | 12,265,330 |
Source
Related
- Allogene Therapeutics, Inc.
- Capital World Investors
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G/A · Capital World Investors · Nov 13, 2025
- Form 4 · Parker Geoffrey M. · Oct 23, 2026
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026